To deepen the exploration and dialogue in the fields of rare disease thrombosis and hemostasis, as well as hereditary cardiovascular diseases in children, we are committed to promoting the innovation and popularization of related diagnostic and treatment technologies, lighting up the path of hope with the light of wisdom, building a bridge of rehabilitation with the power of technology, and forging a shield of health with the spirit of collaboration. The "Rare Disease Professional Committee 2024 Academic Annual Meeting and Establishment Conference of Thrombosis and Hemostasis Group and Pediatric Hereditary Cardiovascular Disease Group" hosted by Chengdu High tech Medical Association and organized by the Rare Disease Professional Committee of Chengdu High tech Medical Association was successfully held in Chengdu on November 22-23, 2024.

96 people from 49 medical institutions inside and outside the province participated in the founding ceremony of the Thrombosis and Hemostasis Group and the Pediatric Hereditary Cardiovascular Disease Group of the Rare Disease Professional Committee of Chengdu High tech Medical Association on November 22, 2024. The conference passed the deliberation and democratically elected the leader and deputy leader of the study group. Professor Chen Rong from the Third People's Hospital of Chengdu was elected as the leader of the Thrombosis and Hemostasis Group, while Professor Chen Jiao from Sichuan Provincial People's Hospital, Professor Chen Shu from the Second Affiliated Hospital of Chongqing Medical University, Professor Zhao Pan from the North Sichuan Medical College Affiliated Hospital, and Professor Zhou Min from Chengdu Women and Children's Central Hospital were elected as the deputy leaders of the Thrombosis and Hemostasis Group (in alphabetical order); Professor Zhou Kaiyu from West China Second Hospital of Sichuan University serves as the honorary leader of the Pediatric Hereditary Cardiovascular Disease Group. Professor Li Yifei from West China Second Hospital of Sichuan University has been elected as the leader of the Pediatric Hereditary Cardiovascular Disease Group. Professors Lei Qian from Sichuan Provincial People's Hospital, Li Tao from West China Hospital of Sichuan University, Tan Xiaoqiu from Southwest Medical University, and Yang Li from the School of Biomedical Engineering of Sichuan University have been elected as the deputy leaders of the Pediatric Hereditary Cardiovascular Disease Group (in alphabetical order).

At the meeting, Comrade Zheng Yanjiang of the special committee also led all members to conduct a party lecture on "Building a Technological Strong Country and Promoting National Rejuvenation".

Professor Ai He, Vice President and Deputy Secretary General of Chengdu High tech Medical Association, and Professor Li Xiaojing, Chairman of the Rare Disease Professional Committee of Chengdu High tech Medical Association, attended the election ceremony and delivered speeches.

On November 23, 2024, at the beginning of the conference, Professor Li Xiaojing, Chairman of the Rare Disease Professional Committee of Chengdu High tech Medical Association, brought a summary report of the committee's work in 2024 to everyone. She not only meticulously counted the series of work done by the special committee in 2024, but also deeply analyzed the challenges and opportunities currently faced. Under her guidance, members of the special committee gathered together and wrote a brilliant chapter in rare disease research.

Subsequently, the academic conference kicked off with warm applause. The opening ceremony was presided over by Professor Zhou Min, the chairman of the special committee, and attended by Professor Yang Renchi from the Hematology Hospital of the Chinese Academy of Medical Sciences, Professor Niu Ting from the West China Hospital of Sichuan University, and President Zhao Cong from the Chengdu High tech Medical Association

At the main venue, Dean Liu Hanmin of West China Second Hospital of Sichuan University brought a wonderful lecture to everyone with his profound academic achievements and forward-looking vision. His explanation was profound and easy to understand, with both theoretical and practical depth, which greatly benefited the attendees.

In the grand event, the sub venue was like two cranes soaring in the sky, dancing gracefully and weaving a beautiful chapter of rare disease research together.

The sub venue of Thrombosis and Hemostasis is like a sparkling galaxy, reflecting the wisdom of doctors. A group of talented individuals gather to explore the secrets of rare disease thrombosis and hemostasis. Their new ideas flow like a spring, like the gentle breeze and rain of spring, silently moistening everything, illuminating the path of scientific research and guiding the direction.

The sub venue of the Pediatric Hereditary Cardiovascular Disease Group is a warm and peaceful academic paradise. A compassionate doctor focuses on the hearts of children and discusses genetic cardiovascular diseases together. Words are filled with deep affection, discussing diagnosis and treatment, looking forward to the future, like warm sunshine shining on the heart and spring breeze brushing the face, bringing hope to the families of sick children, paving the way for health, and interweaving science and humanities to create the beauty of life.

This grand event is a collision of academic knowledge, a fusion of wisdom, and also a baptism of the soul, elevating the spirit. The Rare Disease Professional Committee of Chengdu High tech Medical Association will continue to uphold the concept of "innovation, collaboration, and sharing", work together with colleagues to embark on the profound journey of rare disease research, and bring hope and brightness to more rare disease patients.